GeoVax Labs Inc (GOVX) - Strategic SWOT Analysis Review

GeoVax Labs Inc (GOVX) - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

GeoVax Labs Inc (GeoVax) is a clinical-stage biotech company that develops human vaccines for human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The companys vaccine development programs focus on HIV, Zika virus and hemorrhagic fever viruses (Ebola, Marburg, Lassa fever) and for cancer immunotherapy. Its advanced vaccines under development act against the clade B and clade C subtype of the HIV virus. GeoVax developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.

GeoVax Labs Inc Key Recent Developments

May 22,2019: GeoVax to conduct partnering meetings during BIO International Convention
May 15,2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference
May 14,2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress
May 14,2019: GeoVax Labs announces 2019 first quarter financial results
Mar 27,2019: GeoVax reports 2018 year-end financial results

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.


List of Tables
List of Figures
Section 1 - About the Company
GeoVax Labs Inc - Key Facts
GeoVax Labs Inc - Key Employees
GeoVax Labs Inc - Key Employee Biographies
GeoVax Labs Inc - Major Products and Services
GeoVax Labs Inc - History
GeoVax Labs Inc - Company Statement
GeoVax Labs Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
GeoVax Labs Inc - Business Description
GeoVax Labs Inc - Corporate Strategy
GeoVax Labs Inc - SWOT Analysis
SWOT Analysis - Overview
GeoVax Labs Inc - Strengths
GeoVax Labs Inc - Weaknesses
GeoVax Labs Inc - Opportunities
GeoVax Labs Inc - Threats
GeoVax Labs Inc - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
GeoVax Labs Inc, Recent Deals Summary
Section 4 Companys Recent Developments
May 22, 2019: GeoVax to conduct partnering meetings during BIO International Convention
May 15, 2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference
May 14, 2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress
May 14, 2019: GeoVax Labs announces 2019 first quarter financial results
Mar 27, 2019: GeoVax reports 2018 year-end financial results
Mar 11, 2019: GeoVax provides product development and corporate update
Jan 22, 2019: GeoVax to Present at the 2019 ASM Biothreats Conference
Sep 12, 2018: Geovax to report vaccine development progress at the 12th vaccine congress in Budapest
Aug 29, 2018: GeoVax Strengthens Scientific Staff and Expertise
Aug 14, 2018: GeoVax names David Dodd as Chairman, President and Chief Executive Officer
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


GeoVax Labs Inc, Key Facts
GeoVax Labs Inc, Key Employees
GeoVax Labs Inc, Key Employee Biographies
GeoVax Labs Inc, Major Products and Services
GeoVax Labs Inc, History
GeoVax Labs Inc, Subsidiaries
GeoVax Labs Inc, Key Competitors
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
GeoVax Labs Inc, Recent Deals Summary

List Of Figures


GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

GeoVax Labs Inc (GOVX) - Strategic SWOT Analysis Review

GeoVax Labs Inc (GOVX) - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

GeoVax Labs Inc (GOVX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

GeoVax Labs Inc (GeoVax) develops human vaccines for diseases caused by human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The

USD 250 View Report

Disruptor Profile: MemoMi Labs Inc.

Disruptor Profile: MemoMi Labs Inc.The report provides information and insights into MemoMi Labs Inc.s, including - - Overview of the company and its product offering- Detailed insight into its business

USD 350 View Report

GeoVax Labs Inc (GOVX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

GeoVax Labs Inc (GeoVax) develops human vaccines for diseases caused by human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available